Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duac vs Acanya with Tazorac for Facial Acne
NCT01016977Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, single-blind trial of clindamycin + benzoyl peroxide in acne vulgaris (2 arms), sponsored by GSK. Primary endpoints: Mean Change From Baseline in Erythema at 12 weeks, Mean Change From Baseline in Dryness at 12 weeks and 5 more. Started Oct 2009; status: completed.
02
Drugs
clindamycin + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01016977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01016977.